Effect of Yinxian Capsule Combined withAcitretin on Peripheral Blood NLR, Serum Molecule and Nesfatin-1 Level in Patients with Psoriasis Vulgaris
This paper investigates the effects of Yinxian capsule combined with Awei A capsule on peripheral blood NLR, serum endothelial cell specific molecule and nesfatin-1 in patients with psoriasis vulgaris. After treatment, the effective rate of the observation group (82%) was significantly higher than that of the control group (60%), the difference was statistically significant (P<0.05), and the adverse reaction rate of the observation group (22%) was significantly lower than the adverse group. The response rate (44%) was statistically significant (P<0.05). The neutrophil count and nesfatin-1 levels in the observation group were significantly higher than those in the control group, and the nesfatin-1 levels were statistically significant. The significance of learning (P<0.05) was significantly lower in the peripheral blood NLR and serum endothelial cells than in the control group (P<0.05). Yinxian capsule combined with Awei A capsule is effective in treating psoriasis vulgaris with less adverse reactions, which can significantly reduce the levels of NLR and serum endothelial cell specific molecules in peripheral blood and increase the level of nesfatin-1. It is worthy of clinical promotion.